We aim to transform the lives of patients by establishing Endosomal Escape Vehicle (EEV) therapeutics as a new class of medicines and we aim to become the world’s foremost intracellular therapeutics company. EEV therapeutics are comprised of small cyclic peptides that are chemically conjugated to a wide range of specific and active biological therapeutics.
Lead Underwriter
Cowen and Company, LLC, Evercore Group L.L.C, Goldman Sachs & Co. LLC
